News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
814,168 Results
Type
Article (79806)
Company Profile (544)
Press Release (733817)
Multimedia
Podcasts (150)
Webinars (18)
Section
Business (223988)
Career Advice (3666)
Deals (38318)
Drug Delivery (130)
Drug Development (89045)
Employer Resources (185)
FDA (17783)
Job Trends (16769)
News (381530)
Policy (37641)
Tag
Academia (2995)
Academic (2)
Accelerated approval (14)
Adcomms (33)
Allergies (108)
Alliances (55778)
ALS (123)
Alzheimer's disease (1612)
Antibody-drug conjugate (ADC) (192)
Approvals (17738)
Artificial intelligence (379)
Autoimmune disease (39)
Automation (20)
Bankruptcy (382)
Best Places to Work (12578)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (376)
Bladder cancer (103)
Brain cancer (41)
Breast cancer (407)
Cancer (3196)
Cardiovascular disease (257)
Career advice (3120)
Career pathing (34)
CAR-T (213)
CDC (43)
Cell therapy (582)
Cervical cancer (25)
Clinical research (72673)
Collaboration (1152)
Company closure (3)
Compensation (727)
Complete response letters (38)
COVID-19 (2911)
CRISPR (70)
C-suite (384)
Cystic fibrosis (124)
Data (3243)
Decentralized trials (2)
Denatured (53)
Depression (82)
Diabetes (380)
Diagnostics (6960)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (174)
Drug pricing (155)
Drug shortages (36)
Duchenne muscular dystrophy (159)
Earnings (92865)
Editorial (50)
Employer branding (25)
Employer resources (164)
Events (127140)
Executive appointments (923)
FDA (19637)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1030)
Gene editing (152)
Generative AI (35)
Gene therapy (458)
GLP-1 (938)
Government (5264)
Grass and pollen (7)
Guidances (215)
Healthcare (20849)
HIV (44)
Huntington's disease (31)
IgA nephropathy (44)
Immunology and inflammation (191)
Immuno-oncology (13)
Indications (42)
Infectious disease (3116)
Inflammatory bowel disease (166)
Inflation Reduction Act (13)
Influenza (78)
Intellectual property (129)
Interviews (706)
IPO (17526)
IRA (57)
Job creations (4640)
Job search strategy (2545)
Kidney cancer (14)
Labor market (51)
Layoffs (592)
Leadership (27)
Legal (9449)
Liver cancer (85)
Longevity (12)
Lung cancer (448)
Lymphoma (224)
Machine learning (11)
Management (65)
Manufacturing (469)
MASH (104)
Medical device (14607)
Medtech (14613)
Mergers & acquisitions (21557)
Metabolic disorders (972)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (165)
Neuropsychiatric disorders (47)
Neuroscience (2402)
NextGen: Class of 2025 (7567)
Non-profit (5081)
Now hiring (51)
Obesity (495)
Opinion (290)
Ovarian cancer (106)
Pain (128)
Pancreatic cancer (133)
Parkinson's disease (201)
Partnered (24)
Patents (337)
Patient recruitment (186)
Peanut (55)
People (63623)
Pharmaceutical (115)
Pharmacy benefit managers (25)
Phase I (22524)
Phase II (31692)
Phase III (23832)
Pipeline (1784)
Policy (251)
Postmarket research (3257)
Preclinical (10173)
Press Release (72)
Prostate cancer (156)
Psychedelics (46)
Radiopharmaceuticals (278)
Rare diseases (543)
Real estate (7009)
Recruiting (76)
Regulatory (25819)
Reports (45)
Research institute (2655)
Resumes & cover letters (584)
Rett syndrome (10)
RNA editing (12)
RSV (61)
Schizophrenia (104)
Series A (173)
Series B (120)
Service/supplier (22)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (4167)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (71)
The Weekly (95)
Vaccines (933)
Venture capital (60)
Weight loss (332)
Women's health (52)
Worklife (20)
Date
Today (143)
Last 7 days (580)
Last 30 days (1962)
Last 365 days (33277)
2025 (19282)
2024 (37733)
2023 (42479)
2022 (53845)
2021 (58609)
2020 (57537)
2019 (51145)
2018 (38988)
2017 (36468)
2016 (37142)
2015 (43155)
2014 (37443)
2013 (33788)
2012 (35564)
2011 (35530)
2010 (35023)
Location
Africa (1186)
Alabama (72)
Alaska (7)
Arizona (263)
Arkansas (14)
Asia (48233)
Australia (8318)
California (7984)
Canada (2476)
China (741)
Colorado (339)
Connecticut (353)
Delaware (213)
Europe (109389)
Florida (1194)
Georgia (270)
Hawaii (2)
Idaho (65)
Illinois (732)
India (32)
Indiana (393)
Iowa (18)
Japan (248)
Kansas (115)
Kentucky (32)
Louisiana (17)
Maine (73)
Maryland (1120)
Massachusetts (6084)
Michigan (275)
Minnesota (491)
Mississippi (4)
Missouri (103)
Montana (32)
Nebraska (26)
Nevada (86)
New Hampshire (74)
New Jersey (2237)
New Mexico (31)
New York (2221)
North Carolina (1247)
North Dakota (10)
Northern California (3471)
Ohio (258)
Oklahoma (17)
Oregon (43)
Pennsylvania (1707)
Puerto Rico (18)
Rhode Island (39)
South America (1555)
South Carolina (36)
South Dakota (1)
Southern California (2974)
Tennessee (131)
Texas (1218)
United States (29965)
Utah (231)
Virginia (213)
Washington D.C. (79)
Washington State (691)
West Virginia (4)
Wisconsin (85)
814,168 Results for "johnson and johnson pharmaceutical research and development llc ca".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Johnson & Johnson showcases latest advancements in Alzheimer’s research at AAIC 2025
July 25, 2025
·
7 min read
Press Releases
Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer
July 17, 2025
·
8 min read
Press Releases
Johnson & Johnson Reports Q2 2025 Results; Raises 2025 Outlook
July 16, 2025
·
20 min read
Press Releases
Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference
July 24, 2025
·
1 min read
Press Releases
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2025
July 16, 2025
·
1 min read
Press Releases
Johnson & Johnson’s dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma
June 16, 2025
·
9 min read
Press Releases
Johnson & Johnson seeks first icotrokinra U.S. FDA approval aiming to revolutionize treatment paradigm for adults and adolescents with plaque psoriasis
July 21, 2025
·
17 min read
Press Releases
Johnson & Johnson to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
July 30, 2025
·
1 min read
Press Releases
Johnson & Johnson unveils first-in-human results for pasritamig, showing early anti-tumor activity in prostate cancer
June 2, 2025
·
9 min read
Press Releases
Johnson & Johnson files with U.S. FDA to include new evidence in TREMFYA® (guselkumab) label as the only IL-23 inhibitor to demonstrate significant inhibition of joint structural damage in active psoriatic arthritis
July 30, 2025
·
10 min read
1 of 81,417
Next
